![Overall survival in patients with pancreatic cancer according to the... | Download Scientific Diagram Overall survival in patients with pancreatic cancer according to the... | Download Scientific Diagram](https://www.researchgate.net/publication/320904900/figure/fig1/AS:614317649059844@1523476149163/Overall-survival-in-patients-with-pancreatic-cancer-according-to-the-four-molecular.png)
Overall survival in patients with pancreatic cancer according to the... | Download Scientific Diagram
PLOS ONE: A Thirteen-Gene Expression Signature Predicts Survival of Patients with Pancreatic Cancer and Identifies New Genes of Interest
![Clinicopathologic characteristics, laboratory parameters, treatment protocols, and outcomes of pancreatic cancer: a retrospective cohort study of 1433 patients in China [PeerJ] Clinicopathologic characteristics, laboratory parameters, treatment protocols, and outcomes of pancreatic cancer: a retrospective cohort study of 1433 patients in China [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2018/4893/1/fig-1-full.png)
Clinicopathologic characteristics, laboratory parameters, treatment protocols, and outcomes of pancreatic cancer: a retrospective cohort study of 1433 patients in China [PeerJ]
![Further evidence of the prognostic role of pretreatment levels of CA 19-9 in advanced pancreatic cancer Further evidence of the prognostic role of pretreatment levels of CA 19-9 in advanced pancreatic cancer](http://www.scielo.br/img/revistas/ramb/v56n1/10f01pa.gif)
Further evidence of the prognostic role of pretreatment levels of CA 19-9 in advanced pancreatic cancer
![Clinical Predictors of Second-Line Chemotherapy Benefit in Patients with Pancreatic Cancer | Insight Medical Publishing Clinical Predictors of Second-Line Chemotherapy Benefit in Patients with Pancreatic Cancer | Insight Medical Publishing](https://pancreas.imedpub.com/articles-images/pancreas-overall-survival-prognosis-18-510-g002.png)
Clinical Predictors of Second-Line Chemotherapy Benefit in Patients with Pancreatic Cancer | Insight Medical Publishing
![Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer | Clinical Cancer Research Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer | Clinical Cancer Research](https://clincancerres.aacrjournals.org/content/clincanres/22/10/2565/F1.large.jpg)
Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer | Clinical Cancer Research
![Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study | Scientific Reports Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-64068-3/MediaObjects/41598_2020_64068_Fig2_HTML.png)
Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study | Scientific Reports
![Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study | Scientific Reports Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-64068-3/MediaObjects/41598_2020_64068_Fig4_HTML.png)
Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study | Scientific Reports
![CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer - CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer -](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d08280af-da5a-4f81-af13-176506dbcd37/gr1.jpg)
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer -
![Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c1baf3ce-a0f0-4029-91ba-1d27b84f5657/gr2_lrg.jpg)
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology
![Overall survival curves in patients with advanced pancreatic cancer... | Download Scientific Diagram Overall survival curves in patients with advanced pancreatic cancer... | Download Scientific Diagram](https://www.researchgate.net/publication/315933606/figure/fig4/AS:482008292958216@1491931140685/Overall-survival-curves-in-patients-with-advanced-pancreatic-cancer-according-to-4-risk.png)
Overall survival curves in patients with advanced pancreatic cancer... | Download Scientific Diagram
![Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study | BMC Medicine | Full Text Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study | BMC Medicine | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12916-018-1120-9/MediaObjects/12916_2018_1120_Fig1_HTML.png)
Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study | BMC Medicine | Full Text
![Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study | BMC Medicine | Full Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study | BMC Medicine | Full](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12916-019-1304-y/MediaObjects/12916_2019_1304_Fig1_HTML.png)
Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study | BMC Medicine | Full
Kaplan-Meier estimates of overall survival of patients with pancreatic... | Download Scientific Diagram
![MR-Guided Radiotherapy Prolongs Median Survival for Inoperable, Locally Advanced Pancreatic Cancer | Imaging Technology News MR-Guided Radiotherapy Prolongs Median Survival for Inoperable, Locally Advanced Pancreatic Cancer | Imaging Technology News](https://www.itnonline.com/sites/default/files/Viewray-MRIdian-pancreatic-cancer-trial-data-ASTRO.jpg)
MR-Guided Radiotherapy Prolongs Median Survival for Inoperable, Locally Advanced Pancreatic Cancer | Imaging Technology News
![Overall survival curves in patients with advanced pancreatic cancer... | Download Scientific Diagram Overall survival curves in patients with advanced pancreatic cancer... | Download Scientific Diagram](https://www.researchgate.net/publication/315933606/figure/fig2/AS:482008292958214@1491931140445/Overall-survival-curves-in-patients-with-advanced-pancreatic-cancer-according-to-baseline.png)